Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the international scleroderma renal crisis survey

Seminars in Arthritis and Rheumatism

Volumn 43, Issue 5, 2014, Pages 666-672

  Hudson, Marie ^a,b   Baron, Murray ^a,b   Tatibouet, Solène ^a   Furst, Daniel E ^c,ai   Khanna, Dinesh ^d   Hummers, Laura ^e   Hachulla, Eric ^f   Medsger, Thomas ^g   Steen, Virginia ^h   Alkassab, Firas ⁱ   Johnson, Sindhu ^j   Midtvedt, Oyvind ^k   Szucs, Gabriella ^l   Schiopu, Elena ^m   Carreira, Patricia E ⁿ   Derk, Chris T ^o   Distler, Oliver ^p   Inanc, Murat ^q   Khalidi, Nader ^r   Mahmud, Tafazzul H ^s   Mayes, Maureen D ^t   McKown, Kevin ^u   Proudman, Susanna ^v   Rudnicka, Lidia ^w   Seigel, Stuart ^x   Stein, Jack ^y   Valentini, Gabriele ^z   Yavuz, Sule ^aa   Arbillaga, Hector ^ab   Hazel, Beth ^b   Schulz, Jan ^b   Baker, Milton ^ac   Becker, Mike ^ad   Cabane, Jean ^ae   Chow, Andrew ^r   Christmann, Romy ^af,ag   Clements, Philip ^c   Csuka, Mary Ellen ^ah   Hanke, Katharina ^ad   Kötter, Ina ^aj   Jacobsen, Soren ^ak   Kur, Jason ^al   Lally, Edward V ^am   Ligier, Sophie ^an   Mittoo, Shikha ^ao   Peschken, Christine ^ao   De La Pena Lefebvre, Paloma Garcia ^ap   Queyrel, Viviane ^aq   Silver, Richard ^ar   Simms, Robert ^as   Sondergaard, Klaus ^at   Troyanov, Yves ^au   Turi, Maria C ^av   Varga, John ^aw   Vlachoyiannopoulos, Panayiotis G ^ax   Voskuyl, Alexandre E ^ay   Yeadon, Carol ^az   Westhovens, Rene ^ba   more..

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f UNIV LILLE   (France)

^g UNIVERSITY OF PITTSBURGH   (United States)

^h GEORGETOWN UNIVERSITY   (United States)

ⁱ UNIVERSITY OF MASSACHUSETTS   (United States)

^j UNIVERSITY HEALTH NETWORK   (Canada)

^k OSLO UNIVERSITY HOSPITAL   (Norway)

^l UNIVERSITY OF DEBRECEN   (Hungary)

^m UNIVERSITY OF MICHIGAN   (United States)

ⁿ HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^o THOMAS JEFFERSON UNIVERSITY   (United States)

^p UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^q ISTANBUL UNIVERSITY   (Turkey)

^r MCMASTER UNIVERSITY   (Canada)

^s Shaikh Zayed Hospital and Federal Postgraduate Medical Institute   (Pakistan)

^t UNIVERSITY OF TEXAS   (United States)

^u UNIVERSITY OF WISCONSIN MADISON   (United States)

^v ROYAL ADELAIDE HOSPITAL   (Australia)

^w MEDICAL UNIVERSITY OF WARSAW   (Poland)

^x Hospital of Kelowna   (Canada)

^y SCARBOROUGH HOSPITAL   (Canada)

^z SECOND UNIVERSITY OF NAPLES   (Italy)

^aa MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^ab Chinook Regional Hospital   (Canada)

^ac Humboldt University ^*

^ad HUMBOLDT UNIVERSITY   (Germany)

^ae HÔPITAL SAINT ANTOINE   (France)

^af UNIVERSITY OF SÃO PAULO   (Brazil)

^ag BOSTON UNIVERSITY   (United States)

^ah MEDICAL COLLEGE OF WISCONSIN   (United States)

^ai UNIVERSITY OF CALIFORNIA   (United States)

^aj UNIVERSITY OF TÜBINGEN   (Germany)

^ak Mental Health Services CPH   (Denmark)

^al UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^am BROWN UNIVERSITY   (United States)

^an MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^ao UNIVERSITY OF MANITOBA   (Canada)

^ap HOSPITAL RAMÓN Y CAJAL   (Spain)

^aq UNIVERSITY HOSPITAL OF NICE   (France)

^ar MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^as BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^at AARHUS UNIVERSITY HOSPITAL   (Denmark)

^au HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^av UNIVERSITY OF CHIETI   (Italy)

^aw NORTHWESTERN UNIVERSITY   (United States)

^ax UNIVERSITY OF ATHENS   (Greece)

^ay VU UNIVERSITY AMSTERDAM   (Netherlands)

^az UNIVERSITÉ DE MONTRÉAL   (Canada)

^ba UNIVERSITY HOSPITALS LEUVEN   (Belgium)

more..

Author keywords

ACE inhibitors; Scleroderma; Scleroderma renal crisis

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PREDNISONE;

ADULT; ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; DRUG EXPOSURE; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RAYNAUD PHENOMENON; RENAL REPLACEMENT THERAPY; RISK FACTOR; SCLERODERMA; SCLERODERMA RENAL CRISIS; TREATMENT OUTCOME; AGED; COMPLICATION; KIDNEY DISEASES; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SYSTEMIC SCLEROSIS;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX;

EID: 84898780891     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2013.09.008     Document Type: Article

References (11)

1. Steen V.D. Scleroderma renal crisis. Rheum Dis Clin North Am 2003, 29:315-333.
2. Steen V.D., Medsger T.A. Long-term outcomes of scleroderma renal crisis. Ann Intern Med 2000, 133:600-603.
3. Steen V.D., Medsger T.A., Osial T.A., Ziegler G.L., Shapiro A.P., Rodnan G.P. Factors predicting development of renal involvement in progressive systemic sclerosis. Am J Med 1984, 76:779-786.
4. Walker U.A., Tyndall A., Czirjak L., Denton C., Farge-Bancel D., Kowal-Bielecka O., et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 2007, 66:754-763.
5. Denton C., Black C. Scleroderma-clinical and pathological advances. Best Pract Res Clin Rheumatol 2004, 18:271-290.
6. Teixeira L., Mouthon L., Mahr A., Berezne A., Agard C., Mehrenberger M., et al. Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients. Ann Rheum Dis 2008, 67:110-116.
7. Penn H., Howie A.J., Kingdon E.J., Bunn C.C., Stratton R.J., Black C.M., et al. Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM 2007, 100:485-494.
8. Penn H., Denton C.P. Diagnosis, management and prevention of scleroderma renal disease. Curr Opin Rheumatol 2008, 20:692-696.
9. Hudson M., Baron M., Lo E., Weinfeld J., Furst D., Khanna D. An international, web-based, prospective cohort study to determine if the use of ACE inhibitors prior to the onset of scleroderma renal crisis is associated with worse outcome-methodology and preliminary results. Int J Rheumatol 2010, [Article ID 347402].
10. Guillevin L., Berezne A., Seror R., Teixeira L., Pourrat J., Mahr A., et al. Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls. Rheumatology (Oxford) 2012, 51:460-467.
11. Steen V.D., Mayes M.D., Merkel P.A. Assessment of kidney involvement. Clin Exp Rheumatol 2003, 21(3 Suppl. 29):S29-S31.